comparemela.com

Latest Breaking News On - Jan moller mikkelsen - Page 1 : comparemela.com

Wedbush Keeps Their Buy Rating on Ascendis Pharma (ASND)

In a report released today, Andreas Argyrides from Wedbush reiterated a Buy rating on Ascendis Pharma (ASND – Research Report), with a pri.

Andreas argyridesAscendis pharmaMoonlake immunotherapeuticsHarald rauJan moller mikkelsenBerenberg bankResearch reportBiomarin pharmaceuticalStrong buy

Bank of America Securities Sticks to Its Buy Rating for Ascendis Pharma (ASND)

Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Ascendis Pharma (ASND – Research Report) yesterday and set a pr.

United statesAscendis pharmaTazeen ahmadFargo derek archilaJan moller mikkelsenHarald rauMorgan stanleyApellis pharmaceuticalsAmerica securitiesResearch reportWells fargoDerek archila

Berenberg Bank Reaffirms Their Buy Rating on Ascendis Pharma (ASND)

In a report released today, Caroline Palomeque from Berenberg Bank maintained a Buy rating on Ascendis Pharma (ASND – Research Report), wi.

Caroline palomequeHarald rauAscendis pharmaJan moller mikkelsenBerenberg bankAnavex life sciencesResearch reportStrong buy

Wedbush Keeps Their Buy Rating on Ascendis Pharma (ASND)

In a report released today, Andreas Argyrides from Wedbush reiterated a Buy rating on Ascendis Pharma (ASND – Research Report), with a pri.

Jan moller mikkelsenHarald rauAscendis pharmaAndreas argyridesResearch reportBiomarin pharmaceuticalModerate buy

Goldman Sachs Keeps Their Buy Rating on Ascendis Pharma (ASND)

In a report released today, Paul Choi from Goldman Sachs maintained a Buy rating on Ascendis Pharma (ASND – Research Report). The company&.

Jan moller mikkelsenPaul choiHarald rauAscendis pharmaBio pharmaGoldman sachsResearch reportBridgebio pharmaModerate buy

vimarsana © 2020. All Rights Reserved.